Within the plethora of unpaired neuronal mechanismsproposed asdruggable targets for AD,12 the discoveryof ladostigil13 signed a milestone in studyingthe dual-targeting inhibition of acetylcholinesterase (AChE) and monoamineoxidases (MAOs). This evidence concerns the gene ACHE and Alzheimer disease.